// App-Quantinova.ai

PB0205 : Hypodysfibrinogenemia with a New Heterozygous Mutation in Fibrinogen in a Patient with Thrombotic Complications

Researchers

Presenter

  • S. Hadjali - Saichi

Principal Investigators

  • K. Guenounou - Guemmour

  • P. De Mazancourt

  • I. Frigaa

Medical Centers

  • Center for Hemobiology-Blood Transfusion, Mustapha University Hospital, Faculty of Medicine of Algiers, Algiers, Algeria

  • Biology Laboratory of Saint-Germain en Lay, Paris, France

Locations

  • Algeria

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Fibrinogen

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved